Literature DB >> 11665870

The use of analgesics in patients with asthma.

S Levy1, G Volans.   

Abstract

Aspirin (acetylsalicylic acid) and other nonsteroidal anti-inflammatory drugs (NSAIDs) cause deterioration in respiratory function in approximately 10% of adults with asthma and a smaller proportion of children with asthma. We propose evidence-based guidelines for the safe use of NSAIDs in individuals with asthma following systematic review of data from the last 10 years relevant to the use of these drugs in such patients. We would currently recommend that patients with asthma who are known to be intolerant of NSAIDs or who exhibit any of the high risk clinical features for intolerance to these drugs (severe asthma, nasal polyps or chronic rhinosinusitis) should use NSAIDs only under close medical supervision. In those with high risk features formal aspirin provocation testing would be recommended prior to the therapeutic use of NSAIDs. Those individuals with asthma who regularly use NSAIDs can continue to do so but should be warned that intolerance to NSAIDs can develop late in life. Lack of relevant experimental evidence precludes the production of evidence-based guidelines for the group of patients with asthma who do not exhibit high risk clinical features and who have never before used NSAIDs. We would currently recommend that this group be treated as potentially intolerant to NSAIDs and use of these drugs can only be recommended under medical supervision but note that further studies and clinical experience could be expected to relax this restriction for many patients. Recent data have suggested that frequent use of paracetamol (acetaminophen) may contribute to a deterioration of respiratory function in asthma. A small proportion of patients with asthma who are NSAID-intolerant experience short-lived deterioration in respiratory function with the use of high doses of paracetamol but this is uncommon and has not been implicated in life-threatening reactions. Routine warnings about paracetamol use in asthma are, therefore, not warranted. Medical personnel, however, should be aware of the potential for worsening of symptoms in some individuals with asthma using paracetamol and institute formal investigation or withdrawal of the drug if they suspect such a reaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11665870     DOI: 10.2165/00002018-200124110-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  57 in total

1.  Paracetamol and asthma.

Authors:  I C Wong
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Paracetamol and asthma.

Authors:  A Varner
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Paracetamol and asthma.

Authors:  B Balzer
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma.

Authors:  A Pawlowicz; W R Williams; B H Davies
Journal:  Allergy       Date:  1991-08       Impact factor: 13.146

5.  Aspirin intolerance in chronic childhood asthma: Detected by oral challenge.

Authors:  G S Rachelefsky; A Coulson; S C Siegel; E R Stiehm
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

6.  Severe asthma attacks precipitated by NSAIDs.

Authors:  T Y Chan
Journal:  Ann Pharmacother       Date:  1995-02       Impact factor: 3.154

7.  Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.

Authors:  E Nizankowska; A Bestyńska-Krypel; A Cmiel; A Szczeklik
Journal:  Eur Respir J       Date:  2000-05       Impact factor: 16.671

8.  Asthma caused by topical application of ketorolac.

Authors:  G L Sitenga; E B Ing; R G Van Dellen; B R Younge; J A Leavitt
Journal:  Ophthalmology       Date:  1996-06       Impact factor: 12.079

9.  Asthma death induced by ibuprofen.

Authors:  L Antonicelli; A Tagliabracci
Journal:  Monaldi Arch Chest Dis       Date:  1995-08

10.  Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.

Authors:  A R Fischer; M A Rosenberg; C M Lilly; J C Callery; P Rubin; J Cohn; M V White; Y Igarashi; M A Kaliner; J M Drazen
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

View more
  12 in total

1.  Aspirin induced asthma: clinical relevance of finding was not explained.

Authors:  Indu Sivanandan; Stephen M Robinson
Journal:  BMJ       Date:  2004-05-01

2.  Pre- and post-operative management of dental implant placement. Part 1: management of post-operative pain.

Authors:  G Bryce; D I Bomfim; G S Bassi
Journal:  Br Dent J       Date:  2014-08       Impact factor: 1.626

3.  National Athletic Trainers' Association position statement: management of asthma in athletes.

Authors:  Michael G Miller; John M Weiler; Robert Baker; James Collins; Gilbert D'Alonzo
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

4.  Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children.

Authors:  Joanne E Sordillo; Christina V Scirica; Sheryl L Rifas-Shiman; Matthew W Gillman; Supinda Bunyavanich; Carlos A Camargo; Scott T Weiss; Diane R Gold; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2014-10-28       Impact factor: 10.793

Review 5.  Ibuprofen and increased morbidity in children with asthma: fact or fiction?

Authors:  Ralph E Kauffman; Mary Lieh-Lai
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 6.  Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice.

Authors:  Christine Jenkins; John Costello; Linda Hodge
Journal:  BMJ       Date:  2004-02-21

7.  Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study.

Authors:  T Kurth; R G Barr; J M Gaziano; J E Buring
Journal:  Thorax       Date:  2008-03-13       Impact factor: 9.139

8.  Prenatal and infant paracetamol exposure and development of asthma: the Norwegian Mother and Child Cohort Study.

Authors:  Maria C Magnus; Øystein Karlstad; Siri E Håberg; Per Nafstad; George Davey Smith; Wenche Nystad
Journal:  Int J Epidemiol       Date:  2016-02-09       Impact factor: 7.196

Review 9.  Tolerability of paracetamol.

Authors:  Garry G Graham; Kieran F Scott; Richard O Day
Journal:  Drug Saf       Date:  2005       Impact factor: 5.228

10.  The time delay between drug intake and bronchospasm for nonsteroidal antiinflammatory drugs sensitive patients.

Authors:  Giedre Grigiene; Jolita Norkūnienė; Violeta Kvedariene
Journal:  World Allergy Organ J       Date:  2010-12       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.